A. Mendelowitsch et al., CORTICAL BRAIN MICRODIALYSIS AND TEMPERATURE MONITORING DURING HYPOTHERMIC CIRCULATORY ARREST IN HUMANS, Journal of Neurology, Neurosurgery and Psychiatry, 64(5), 1998, pp. 611-618
Objectives-Critical vascular surgery of the brain or the heart occasio
nally requires total cessation of the circulatory system. Profound hyp
othermia is used to protect the brain from ischaemic injury. This stud
y explores the use of microdialysis to measure metabolic indices of is
chaemia: glutamate, lactate, and pH, and cerebral temperature during p
rofound hypothermia and circulatory arrest. Methods-Effluent from a mi
crodialysis catheter placed in the cerebral cortex of three patients u
ndergoing complete circulatory arrest was continuously sampled. Sample
s were pooled over 10 minute periods and glutamate and lactate concent
rations were measured postoperatively. Brain temperature and pH were m
easured on line intraoperatively. Electroencephalography and monitorin
g of somatosensory evoked potentials and brainstem auditory evoked pot
entials were simultaneously carried out. Results-Patient 1 had normal
glutamate and lactate. PH was 6.75 to 6.85 and increased to 6.9 after
warming ensued. Patient 2 had raised glutamate and lactate during most
measurements. The glutamate concentrations peaked at 305 mu M/l at th
e start of the measurements and fell below 20 mu M/l after warming. Th
e lactate concentrations peaked at 680 mu M/l before cooling, rose to
1040 mu M/l during the cooling process, decreased to 212 mu M/l during
circulatory arrest, and rose again to 620 mu M/l after warming. The p
H started at 7.06 and continued a downward course until stabilising at
a pH of 6.5 after circulatory arrest. Patient 3 had a transient, mild
increase in glutamate and lactate during the cooling and warming peri
od. pH was stable throughout. Conclusion-Microdialysis combined with t
emperature and pH measurements of the cerebral cortex promises to be a
n important tool in detecting cerebral ischaemia. Further studies are
needed to validate our findings and test the feasibility of modifying
ischaemic changes.